NRSA: Mulholland--Ethonal Withdrawal, Stress and Polyamine Neuroprotection

Grants and Contracts Details


Mechanisms underlying ethanol withdrawal-induced neurotoxicity and means to reverse this damage are not completely understood. Research suggests that glucocorticoids and polyamines may contribute to ethanol-associated neurodegeneration. Thus, the broad, long-term objective of this proposal is to establish more precisely the mechanisms involving glucocorticoid-induced exacerbation of ethanol withdrawal (EWD)-mediated damage using organotypic hippocampal slice cultures. To this end, cultures will be exposed chronically to ethanol and withdrawn in the presence of corticosterone. Toxicity will then be assessed using the non-vital fluorescent dye propidium iodide. Some studies suggest that EWDinduced damage may be partially mediated via activation of the polyamine-sensitive portion of NMDA receptors. In addition, corticosterone administration may also influence expression of this polyaminesensitive subunit. These hypotheses will be tested using autoradiographic imaging of spermidine's potentiation of C251]MK-801 binding. The secondary yet therapeutically relevant objective is to examine the efficacy of novel NMDA polyamine-site and glucocorticoid receptor antagonists against corticosterone's potentiation of EWD-induced toxicity. Regardless of the outcomes of the proposed studies, they may provide considerable insight into some of the mechanisms of EWD-mediated hippocampal degeneration, as well as identify potential therapeutic targets for the treatment of alcohol-associated neurodegeneration.
Effective start/end date9/29/039/28/04


  • National Institute on Alcohol Abuse and Alcoholism: $27,028.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.